
209.25 USD (+25.7%)
4 analysts
What does it do?
Balchem Corporation is a U.S. manufacturer of specialty chemicals and nutritional ingredients —animal feed, human nutrition, and industrial chemical ingredients— selling to defensive consumer sectors with stable demand.
Key points
from its scores- ✓Very solid balance sheet8.3
- ✓Strong growth7.1
- ✓Favourable backdrop7.1
- ✕Demanding valuation3.7
- ✕Little or no dividend4.2
AI analysis
bottom line, main risk, context and newsSolid defensive quality and growth, but the valuation premium already discounts the good prospects; wait for a better entry point.
Balchem combines a very solid balance sheet (Net Debt/EBITDA of 0.38, current ratio of 2.67) with strong growth (revenue +11.2%, earnings +18.8%) and a respectable moat (ROIC 15.45%, operating margin 20.85%), but its demanding valuation (P/E 32.76, EV/EBITDA 20.07) limits the appeal at current prices.
The main risk is the demanding valuation (P/E 32.76, FCF yield 2.54%): any slowdown in the 18.8% earnings growth or a persistently high long-term rate environment in the U.S. would compress the multiple.
Context and risks
No recent relevant news and no material exposure to current macro factors: the rise in long-term U.S. rates has a limited effect given its low leverage (Net Debt/EBITDA of 0.38), and its specialty chemicals business for defensive consumption does not depend on energy commodities or conflict shipping routes.
Is Balchem stock cheap or expensive?
at the analysis dateOn P/E and EV / EBITDA, it trades 86% above the Basic Materials median on average.
| Multiple | Company | Sector | Difference |
|---|---|---|---|
| P/E | 32.8 | 19.2 | +71% |
| EV / EBITDA | 20.1 | 10.0 | +101% |
| Price / book | 4.1 | 2.3 | +81% |
| Price / sales | 4.9 | 2.2 | +122% |
Sector: median of the 141 Basic Materials companies analysed. In bold, the multiples used for the comparison.
Valuation score: 3.7 out of 10 (median for Basic Materials: 5.8).
Average analyst target: 209.25 USD, +25.7% versus the price.
A premium can be justified if the company is of higher quality or grows faster than its sector: Quality / Moat 6.0 (sector 5.1), Growth 7.1 (sector 6.8).
Classic formulas with standard assumptions (10.0% growth, 8-9% discount rate). Indicative only: they change a lot with the assumptions and are not a recommendation.
Work out its fair value yourself →How much would you have made investing every month? →
Comparing it with its sector does not say whether it is a good buy: this is not investment advice.
Score by category
0 to 10 · hover overtap each one to see what it measuresKey metrics
at the analysis date · compared with the Basic Materials medianValuation
- P/E
- 32.8
- Forward P/E
- 26.5
- EV / EBITDA
- 20.1
- Price / book
- 4.1
- Price / sales
- 4.9
- PEG
- 3.20
- Market cap
- 5.3B USD
- Enterprise value
- 5.4B USD
Profitability
- ROE
- 12.8%
- ROA
- 8.2%
- ROIC (approx.)
- 15.4%
- Gross margin
- 36.3%
- Operating margin
- 20.9%
- Net margin
- 15.1%
- Free cash flow
- 134.8M USD
- FCF yield
- 2.5%
- Cash conversion
- 50%
Solvency
- Total debt
- 166.7M USD
- Net debt
- 103.5M USD
- Cash
- 63.2M USD
- EBITDA
- 269.4M USD
- Net debt / EBITDA
- 0.38
- Debt / equity
- 12.80
- Current ratio
- 2.67
- Quick ratio
- 1.46
Growth
- Revenue growth
- +11.2%
- Earnings growth
- +18.8%
- EPS (TTM)
- 5.08 USD
- EPS (forward)
- 6.27 USD
Dividend
- Dividend yield
- 0.6%
- Payout
- 18.9%
Risk and market
- Beta
- 0.85
- Analyst consensus
- none (4)
- Target price
- 209.25 USD
- 52-week range
- 139.17 – 183.90
Recent news
All BCPC news →Compare it with its sector
All 141 in Basic Materials →Frequently asked questions about Balchem
Is Balchem stock cheap or expensive?
On P/E and EV / EBITDA, it trades 86% above the Basic Materials median on average. Valuation score: 3.7 out of 10 (median for Basic Materials: 5.8). Average analyst target: 209.25 USD, +25.7% versus the price. This is not investment advice.
What score does Balchem get on MeridIAn Screener?
It scores 5.9 out of 10, rank 1,053 of 2,130 (better than 47% of the companies analysed). Its strongest category is Financial health (8.3) and its weakest, Valuation (3.7). Analysis of 08/10/2026.
What is Balchem's P/E ratio?
Its P/E is 32.8: the share price equals 32.8 times earnings per share over the last 12 months. The Basic Materials median is 19.2. Based on the earnings analysts expect, the forward P/E is 26.5.
How much is Balchem worth on the stock market?
Its market capitalisation is 5.3B USD and its enterprise value, debt included, is 5.4B USD.
How much debt does Balchem have?
Its net debt (debt minus cash) is 103.5M USD. That is 0.38 times its EBITDA; the Basic Materials median is 1.41.
Does Balchem pay a dividend?
Yes: its dividend yield is 0.58% and it pays out 19% of its earnings.
How has Balchem stock performed over the last year?
It has risen 15.8% over the last year, excluding dividends. Over the last 52 weeks it has traded between 139.17 and 183.90 USD. Past performance does not guarantee future results.
What do analysts think of Balchem?
4 analysts cover it; their average recommendation is “none” and their average target is 209.25 USD (+25.7% versus the price). It is an estimate, not market data.
